Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_197174eb93dc97e67c46af4d62c1e9e7 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-622 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 |
filingDate |
2008-08-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c82e1b1467502e6c7287588a15018aba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a8d14e0f1797bb510949dfba3de6a69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d92b2fcc7fdaef36a9640325b827149 |
publicationDate |
2014-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2453592-T3 |
titleOfInvention |
Anti-RANTES antibodies and methods of use thereof |
abstract |
Isolated fully human monoclonal human anti-RANTES antibody or fragment thereof, wherein said antibody comprises: a) a VH CDR1 region comprising the amino acid sequence of SEQ ID NO: 8; a CDR2 region of VH comprising the amino acid sequence of SEQ ID NO: 9; a CDR3 region of VH comprising the amino acid sequence of SEQ ID NO: 20; a CDR1 region of VL comprising the amino acid sequence of SEQ ID NO: 14; a CDR2 region of VL comprising the amino acid sequence of SEQ ID NO: 15; and a CDR3 region of VL comprising an amino acid sequence of SEQ ID NO: 16, or b) a CDR1 region of VH comprising the amino acid sequence of SEQ ID NO: 8; a CDR2 region of VH comprising the amino acid sequence of SEQ ID NO: 9, a CDR3 region of VH comprising the amino acid sequence of SEQ ID NO: 10; a CDR1 region of VL comprising the amino acid sequence of SEQ ID NO: 14; a CDR2 region of VL comprising the amino acid sequence of SEQ ID NO: 15; and a CDR3 region of VL comprising an amino acid sequence of SEQ ID NO: 16 or c) a CDR1 region of VH comprising the amino acid sequence of SEQ ID NO: 28; a CDR2 region of VH comprising the amino acid sequence of SEQ ID NO: 29; a CDR3 region of VH comprising the amino acid sequence of SEQ ID NO: 30, a CDR1 region of VL comprising the amino acid sequence of SEQ ID NO: 34; a CDR2 region of VL comprising the amino acid sequence of SEQ ID NO: 35; and a CDR3 region of VL comprising an amino acid sequence of SEQ ID NO: 36; wherein said antibody binds to RANTES. |
priorityDate |
2007-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |